We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsLeafly PicksCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Leafly Picks
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
  • Help
  1. Home
  2. News
  3. Politics
  4. New DEA Report Finds Cannabis is Least of America’s Drug Worries
  • News
  • Cannabis 101
  • Growing
  • Strains & products
  • CBD
  • Politics
  • Health
  • Lifestyle
  • Science & tech
  • Industry
  • Reports
  • Canada
  • Podcasts
  • Leafly Lists
Politics

New DEA Report Finds Cannabis is Least of America’s Drug Worries

Lisa RoughLast updated July 28, 2020

There has been a lot of the bravado coming out of the Drug Enforcement Agency on cannabis lately, including a statement from interim DEA chief Chuck Rosenberg in which he scoffs at the use of cannabis as medicine, but thanks to a new report from the administration, it’s clear that the nation’s law enforcement have a difference of opinion.

The 2015 National Drug Threat Assessment Summary asked a sample of 1,100 law enforcement officers what they perceived to be the nation’s biggest drug threat. Officers responded and once again, for the fifth time in a row, cannabis was considered the least of law enforcement concerns, with just six percent of respondents reporting marijuana as the largest threat — the lowest that cannabis has ever ranked. 

Unsurprisingly, heroin tops the list, with 38 percent reporting that heroin is the nation’s biggest concern. Heroin use has increased in the past five years, although abuse of prescription pills has tapered off since 2013 and has become less of a concern for law enforcement.

The latest poll from Gallup shows that a clear majority of 58 percent of Americans now support the legalization of marijuana, and yet the Drug Enforcement Administration clings to outdated concepts and inaccurate facts. It was recently discovered that the DEA has been using their own interpretation of an amendment to continue using federal funds for raids on marijuana businesses operating in legal states. Luckily, a judge ruled that the organization must keep their hands off legitimate cannabis businesses, but the act in itself shows a blatant disregard for the public's interest.

The DEA reported that legalization and widespread decriminalization “will allow small-scale domestic criminal organizations to cultivate and traffic marijuana with more freedom than in the past.” 

Sigh. Even legitimate, state-licensed, federal-tax-paying medical and/or recreational cannabis companies are still considered to be “criminal.”

The DEA report also found that cannabis potency has increased in recent years and that they consider cannabis concentrates to be a “growing concern,” but despite a reported 46,000 American deaths from drug overdose, not a single death was attributed to cannabis, high-potency or otherwise.

The numbers speak for themselves. Does the DEA speak for America, though? #JustSayKnow

Catch up on the DEA chief calling medical marijuana a "joke," with five medical studies proving otherwise: 

 DEA Chief Calls Medical Marijuana “a Joke,” But These 5 Studies Say Otherwise

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
DEA
Lisa Rough
Lisa Rough
Lisa is a former associate editor at Leafly, where she specialized in legislative cannabis policy and industry topics.
View Lisa Rough's articles

The latest in Politics

  • How US import tariffs are impacting cannabis prices and products image
    How US import tariffs are impacting cannabis prices and products
    Leafly Staff
  • Ohioans must activate to defend cannabis freedoms from lawmakers image
    Ohioans must activate to defend cannabis freedoms from lawmakers
    David Downs
  • Montanans must activate to protect legalization in 2025 image
    Montanans must activate to protect legalization in 2025
    David Downs
  • Analysis: Don’t hold your breath for legalization under Trump 2.0 image
    Analysis: Don’t hold your breath for legalization under Trump 2.0
    David Downs
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.